Key account management Leads Medicine 
pharmaphorum
DECEMBER 23, 2022
Leading companies will empower their teams to act quickly, compliantly, and with a unified view of the HCP.”. Reliable, measurable omnichannel behaviours, such as the use of video to complement in-person engagement, will become leading indicators. Marketing data will surpass health data as a leading signal for pharma advertisers.
Star OUTiCO
FEBRUARY 1, 2022
My career started as an RGN, and I continue to work in the NHS in renal medicine. I’ve worked in the pharmaceutical industry full-time for 24 years across a variety of roles but mostly within Leadership and Market Access, and latterly heading up Key Account Management at Boehringer-Ingelheim. Focus on Service-Redesign.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Quantified
APRIL 18, 2022
In the context of a new medical innovation where there is a high unmet patient need, this means patients are not getting rapid access to medicines that can positively impact or even extend their lives. Prescription medicine companies simply have fewer ways of reaching audiences at scale compared to nearly any other industry.
pharmaphorum
SEPTEMBER 2, 2022
Takeda Connect provides oncologists with information about their Key Account Manager and Medical Science Liaison, alongside direct access at the click of a button. Beyond external engagement, the acceleration of data, digital, and AI are making business operations more effective and efficient, leading to greater innovation.
Evolve Your Success
JANUARY 31, 2023
From a management perspective, what happens is that you see managers who begin to believe that they can lead their team from behind their desks. Your services help managers have better relationships with their teams. The managers may be trying to lead from behind the desk. There are all these signals.
Pharmaceutical Technology
MARCH 22, 2023
The need for quality When it comes to injectable medicine, achieving product sterility through aseptic manufacturing is of critical importance. In August 2022, a final revision of the EU GMP Annex 1 was released stressing the importance of a holistic contamination control strategy in the manufacture of sterile medicinal products.
Pharmaceutical Technology
MAY 23, 2023
We’re also thinking of a solution for how to transfer medicine and investigational medical products for our clients to the people that need them,” explains Olga Vizgalova, managing director for Ukraine at Oximio. But it doesn’t end there. “We’re All our clients received that. Credit: Oximio.
Expert insights. Personalized for you.
105 
Let's personalize your content